Torrent Pharmaceuticals zooms on reporting 24% rise in Q2 consolidated net profit
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
Torrent Pharmaceuticals is currently trading at Rs. 1936.00, up by 61.80 points or 3.30% from its previous closing of Rs. 1874.20 on the BSE.
The scrip opened at Rs. 1911.45 and has touched a high and low of Rs. 1952.95 and Rs. 1822.80 respectively. So far 16059 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 2099.95 on 10-Aug-2023 and a 52 week low of Rs. 1446.15 on 01-Mar-2023.
Last one week high and low of the scrip stood at Rs. 1952.95 and Rs. 1822.80 respectively. The current market cap of the company is Rs. 65404.58 crore.
The promoters holding in the company stood at 71.25%, while Institutions and Non-Institutions held 21.16% and 7.60% respectively.
Torrent Pharmaceuticals has reported results for second quarter ended September 30, 2023 (Q2FY24).
The company has reported 20.22% rise in its net profit at Rs 327 crore for Q2FY24 as compared to Rs 272 crore for the same quarter in the previous year. Total income of the company increased by 11.45% at Rs 2,161 crore for Q2FY24 as compared Rs 1,939 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 23.72% rise in its net profit at Rs 386 crore for the quarter under review as compared to Rs 312 crore for the same quarter in the previous year. Total income of the company increased by 16.43% at Rs 2,686 crore for Q2FY24 as compared Rs 2,307 crore for the corresponding quarter previous year.
